Last reviewed · How we verify
TACRINE
At a glance
| Generic name | TACRINE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1993 |
Approved indications
Common side effects
Key clinical trials
- Comparing Dual-mobility Cups Versus Unipolar Cups for Unselected Primary Total Hip Arthroplasty by Direct Anterior Approach (NA)
- A Digital Health Program for Non-Communicable Disease Prevention in a Workplace Setting in Thailand (NA)
- Influence of Spinal Deformity on THA
- PFNA vs Dual Mobility in Treatment of Unstable Trochanteric Fractures (PHASE2)
- Clinical Study and Economic Analysis of an Intraoperative Navigation System for Total Hip Arthroplasty (NA)
- Chlorzoxazone in Hip and Knee Arthroplasty (PHASE4)
- "True Incidence of Hip Dislocation After Primary THA - a Nationwide Population Study"
- Minimal Invasive Surgery in Total Hip Arthroplasty Patients; Short- and Long Term Results (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |